OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors
What You Should Know: - OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing
Source: hitconsultant.net